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Activation of Prp28 ATPase by phosphorylated
Npl3 at a critical step of spliceosome remodeling
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1,

Splicing, a key step in the eukaryotic gene-expression pathway, converts precursor messenger RNA (pre-mRNA) into mRNA by excising introns and ligating exons. This task is
accomplished by the spliceosome, a macromolecular machine that must undergo sequential
conformational changes to establish its active site. Each of these major changes requires a
dedicated DExD/H-box ATPase, but how these enzymes are activated remain obscure. Here
we show that Prp28, a yeast DEAD-box ATPase, transiently interacts with the conserved 5′
splice-site (5′SS) GU dinucleotide and makes splicing-dependent contacts with the U1 snRNP
protein U1C, and U4/U6.U5 tri-snRNP proteins, Prp8, Brr2, and Snu114. We further show that
Prp28’s ATPase activity is potentiated by the phosphorylated Npl3, but not the unphosphorylated Npl3, thus suggesting a strategy for regulating DExD/H-box ATPases. We
propose that Npl3 is a functional counterpart of the metazoan-speciﬁc Prp28 N-terminal
region, which can be phosphorylated and serves as an anchor to human spliceosome.
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complex to promote a U1/U6 switch at the 5′SS 5,6 such that the
U6 snRNA’s invariant ACAGAGA box can bind to 5′SS,
whereupon Brr2 unwinds the U4/U6 RNA duplex within the B
complex to liberate U4 snRNP.
We have previously shown that yeast Prp28 (hereafter Prp28)
can be made dispensable upon weakening U1 snRNP/5′SS
interaction by speciﬁc alterations of U1 snRNP components,
including U1C protein and U1 snRNA6,7, suggesting these
components are Prp28’s molecular targets. Prp28, however, differs from its human counterpart (hPrp28) by lacking a metazoanspeciﬁc N-terminal region8 and by existing in free form rather
than being a part of U5-snRNP9. Both puriﬁed Prp28 and hPrp28
exhibit negligible ATPase activity10,11, raising the hypothesis that
a cofactor, a spliceosomal environment, or both are required to
turn on their activities in the right place at the right time. The
present study seeks to investigate how Prp28 comes in contact
with the spliceosome and how its ATPase activity can be
potentiated within the spliceosome environment.

plicing is an essential step in the eukaryotic gene-expression
pathway that converts pre-mRNA into mRNA by excising
introns and ligating exons. This task, which demands
single-nucleotide precision, is accomplished by the spliceosome, a
macromolecular machine made of ﬁve small nuclear RNAs
(snRNAs) and numerous proteins1–3. Unique among ribonucleoprotein (RNP) machines, the spliceosome is assembled anew
upon each intron and undergoes sequential conformational
changes to establish its active site. Each of these major changes1–3
requires a dedicated DExD/H-box ATPase4, but how these
enzymes are rigorously regulated to trigger speciﬁc conformational changes remain obscure.
Spliceosome assembly follows a canonical pathway1–3 in which
the pre-mRNA 5′SS is ﬁrst recognized by U1 snRNP to form the
early (E) complex, which then progresses through complexes A
(containing U1 and U2 snRNPs), pre-B (U1, U2, and U4/U6.U5
tri-snRNP), B (U1 snRNP departed), Bact (U4 snRNP departed;
1st chemical step activation), B* (5′SS cleavage and lariat intron
formation), C (2nd step activation), C* (3′SS cleavage), and P
(product complex with ligated exons and lariat intron). Release of
the spliced mRNA creates the intron lariat spliceosome (ILS;
containing U2/5/6 and lariat intron), which is dissembled to
recycle the snRNPs and degrade the intron. At almost every step
of the way, one or two DExD/H-box ATPases are dedicated to
driving this pathway forward4. For example, Prp28 acts on pre-B

0.

02

K27
0.02

0.05

K41

0.2

2

0.02

- + - + - + - +

2

0

05
0.
2

02

0.

0.

05
0.
2

0

c

Anti-Prp28
2

02

PAS
0.

0.

0

05
0.
2
2

ATP (mM)

Splicing Reaction
0.

a

nt

Results and discussion
Prp28 contacts several key spliceosomal proteins during splicing. To explore the preceding hypothesis, we ﬁrst examined
Prp28’s presence in various splicing complexes enriched by low
ATP concentrations12 (Fig. 1a, lanes 11–15 and Supplementary
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Fig. 1 Prp28 contacts key proteins at the heart of spliceosome. a Low ATP traps a transient interaction of Prp28 with the spliceosome. Splicing reactions
(lanes 1–5) were done in V5-tagged Prp28 extracts at 0, 0.02, 0.05, 0.2, or 2 mM ATP and a portion was subjected to immunoprecipitation without
antibody (PAS; lanes 6–10) or with anti-V5 antibody (lanes 11–15). Relative loadings are 1:10 for splicing reactions alone (lanes 1–5) vs. immunoprecipitated
reactions (lanes 6–15). Positions of pre-mRNA, splicing intermediates, and mRNA are indicated to the left. The experiment was repeated three times with
similar results. b Schematic diagram showing a BPA-marked Prp28 cross-linked to protein X in a spliceosome assembled on MS2 stem-loop-tagged ACT1
pre-mRNA, which can be pulled down by MS2-maltose-binding protein-(MS2-MBP)-conjugated agarose beads. Thunderbolt, 365-nm UV irradiation.
c Prp28-BPA cross-linked species (Prp28-X) detected by using anti-Prp28, or using anti-HA and anti-V5 tag antibody for Prp28-tagged experiments. K27,
K41, K82, and K136 are the amino-acid residues in Prp28 replaced by BPA. (−) and (+), without or with UV irradiation, respectively. Filled circle,
uncrosslinked Prp28. Asterisk, nonspeciﬁc background band. Detection of MS2-MBP serves as a loading control. The experiments were repeated three
times with similar results. d Identiﬁcation of the X proteins as Prp8, Brr2, Snu114, and U1C by using anti-Prp8, anti-Brr2, anti-Snu114, or anti-V5 (U1C-V5)
antibody, respectively. The experiments were repeated three times with similar results. e Schematic summary of the cross-linking data. Splicing complexes
accumulated at various ATP concentrations are shown to the left. The changing amount of Prp28 associated with the spliceosome is depicted to the right.
Source data are provided as a Source Data ﬁle.
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Fig. 1a, b). The amount of the pre-mRNA co-precipitated by antiPrp28 antibody peaked at 0.05 mM ATP (Fig. 1a, lane 13). A
reciprocal experiment using MS2 loop-tagged pre-mRNA for
pulling down splicing complexes yielded the same result (Supplementary Fig. 1a, b). Together, these data suggest that ATP
hydrolysis is required for releasing Prp28 from splicing complexes
(Fig. 1e and Supplementary Fig. 1c).
To understand Prp28’s action within the protein-rich RNP
environment of the spliceosome13, we adapted a p-benzoylphenylalanine (BPA; a photoactivatable unnatural amino acid)
based cross-linking method for detecting potentially transient
protein-protein interactions14,15. In this approach, BPA is sitespeciﬁcally incorporated in vivo into Prp28 using an orthogonal
pair of aminoacyl tRNA synthetase and suppressor tRNA (UAG).
There were several considerations for choosing which amino-acid
residues for BPA replacement. We ﬁrst selected hydrophilic
amino-acid residues that are not strictly conserved among DExD/
H-box proteins, arguing that they are more likely to situate on
Prp28’s surface and that their BPA replacements are less likely to
signiﬁcantly impact on Prp28’s function. We then used the
structural information of Vasa16, another DExD/H-box protein, to
computationally model Prp28 structure and to guide our ﬁnal
selections17. Among the 42 UAG (stop codon)-containing PRP28
alleles tested, 36 supported cell growth in BPA-containing media
(Supplementary Data 4). We next prepared active splicing extracts
(Supplementary Fig. 1d) from these engineered strains for
performing BPA-mediated protein-protein cross-linking (Fig. 1b).
Among the 12 extracts that yielded detectable Prp28-cross-linked
products, we found that most of those BPA-replaced residues are
located on the surface of RecA1 domain or in the N-terminal
region of Prp28 that is not resolved in the crystal structure10
(Supplementary Fig. 2). Data from the Prp28-K27BPA, -K41BPA,
-K82BPA, and -K136BPA experiments are shown in Fig. 1c. These
cross-linked species are splicing-dependent because their appearances depend on the presence of pre-mRNA, intron, functional 5′
SS and branch site, and UV irradiation (Fig. 1c and Supplementary Fig. 3). The addition of RNase A after UV irradiation did not
abolish the cross-linking signals, suggesting that Prp28 makes
direct contacts with targeted proteins (Supplementary Fig. 3). We
then scaled up the Prp28-K136BPA reaction for mass-spectrometry
analysis (Supplementary Fig. 4), which led to the identiﬁcation of
Prp8, a very large splicing factor in the spliceosome18 (Supplementary Fig. 4 and Supplementary Data 5). Immunoblotting using
anti-Prp8 and anti-Prp28 antibodies conﬁrmed this ﬁnding
(Supplementary Figs. 1e, f and 4c). On the basis of a combination
of cross-linked species’ molecular sizes, Prp8’s location in
published U4/U6.U5 tri-snRNP structures19,20, and Prp28’s
known genetic interactions6,7, we systematically interrogated other
cross-linked proteins using a panel of antibodies. This effort
identiﬁed two additional U5-snRNP proteins, Brr2 and Snu114, as
well as U1C (Fig. 1d and Supplementary Fig. 3). There are,
however, several other cross-linked species (Supplementary
Fig. 1g) that remain to be identiﬁed.
To gain insight into Prp28’s interactions with these four
proteins during spliceosomal assembly, we performed crosslinking experiments by varying ATP concentrations ranging from
0.02 to 2 mM (Fig. 1c–e), which yielded several key observations.
First, Prp28 indeed contacts U1C as predicted6,7, but only at ATP
concentrations below 2 mM ATP, consistent with U1 snRNP’s
departure prior to the occurrence of splicing chemistry at 2 mM
ATP5,6. The observed Prp28/U1C interaction at 0.02 mM ATP
may correspond to Prp28’s ATP-independent role in stabilizing
early splicing complexes21. Second, Prp28 can contact Prp8, Brr2,
and Snu114 (e.g., K136BPA), suggesting an intimate functional
relationship with U5-snRNP, reminiscent of hPrp28’s role in
facilitating U4/U6.U5 tri-snRNP integration into the
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spliceosome22,23. Third, Prp28’s contacts with Brr2 suggest that
the two DExD/H-box ATPases physically communicate with each
other for sequential removal of U1 snRNP and U4 snRNP. Two
pre-B structures24,25 are now available. In the yeast structure24,
Prp28 cannot be precisely positioned. Our cross-linking data,
though, appears to ﬁt well with both the yeast24 and human25
pre-B structures with respect to the locations of Prp8 and Snu114.
In the human Pre-B structure, the main body of hPrp28 appears
to be distant from the location of Brr2 (Supplementary Fig. 2c
and Supplementary Software 1). Yet, the N-terminal domain of
hPrp28, which is not conserved in yPrp28 (see below), threads
through Prp8 and Snu114 moieties to reach Brr2 (Supplementary
Fig. 2c). In both human and yeast cases, Brr2 is observed24 or
predicted25, respectively, to undergo a rotation and transrelocation in the pre-B-to-B transition24,25. In this light, we note
that in the published yeast Pre-B structure, one of the speculated
locations of Prp28 is close to Brr2 24, while the other location is
not; whereas the human Brr2, upon the predicted dramatic transrelocation25, would also be physically close to the Prp28 main
body. It is therefore tempting to speculate that this transrelocation may then place Brr2 in the vicinity of Prp28 main body
that is made up of the two RecA-like (i.e., the enzymatic)
domains. At the moment, we cannot rule out that the crosslinking between Prp28 and Brr2 can occur without translocation,
because the contact can be through the N-terminal domain of
Prp28. However, as the spliceosome complexes are highly
dynamic during the splicing process, our biochemical approach
might have captured a structurally dynamic, but so far
undetected, intermediate state.
Prp28’s contacts with key spliceosomal proteins are functional.
To assess the physiological relevance of the Brr2 cross-linking
data, we pairwise combined four cross-linking-compromised
prp28 alleles, each containing a 10 amino-acid deletion ﬂanking
the K82, K27, K41, or K136 residues (prp28-K82Δ10, -K27Δ10,
-K41Δ10, or -K136Δ10), with seven brr2 alleles. All double
mutants exhibited synthetic-sick or -lethal phenotypes (Fig. 2a
and Supplementary Fig. 5, Supplementary Table S1), suggesting
that Prp28 and Brr2 are functionally interacting with each other.
To analyze the physiological relevance of the observed crosslinking between Prp8 and Prp28, we performed a genome-wide
genetic screen and uncovered prp8-501, a mutant allele of PRP8
that resulted in a lethal phenotype in the Prp28-bypass background (YHC1-1 prp28Δ)6. This ﬁnding prompted us to test a
panel of 47 other prp8 alleles in a similar manner. Among them,
14 yielded lethality and one caused severe growth defect (Supplementary Data 6). The amino-acid changes inferred from all
these mutant alleles are localized to a ~300-amino-acid region
(1574–1883) partially overlapping with the maintenance of 3′SS
ﬁdelity region (1385–1625) and the structurally deﬁned RNase H
domain (1833–1950)26. Because all of these prp8 alleles are
recessive to the wild-type PRP8 allele, the simplest interpretation
would be that Prp8 acts in concert with Prp28 to promote
U1 snRNP’s departure. We note that genetic interaction between
Prp28 and Snu114 was previously documented27. We next
examined how these crosslink-compromised prp28 alleles impact
on spliceosome remodeling. Chromatin immunoprecipitation
(ChIP) showed that U1 snRNP departure in the prp28-K82Δ10
strain is delayed during co-transcriptional splicing of the ACT1
pre-mRNA (Fig. 2b). Using an alternative in vitro strategy to
monitor the U1 snRNP presence on assembled spliceosome, we
found U1 snRNP accumulated at a higher level in K27Δ10,
K41Δ10, K82Δ10, and K136Δ10 reactions than that in the wildtype reaction and, importantly, the addition of puriﬁed Prp28
rescued this defect (Supplementary Fig. 6b, c).
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Fig. 2 Prp28 genetically interacts with Brr2 and crosslinks to pre-mRNA 5′SS in the pre-B complex. a Growth phenotypes of yeast strains harboring
various combinations of prp28-K82Δ10 and brr2 alleles spotted in a dilution series to YPD medium at 30 °C. Asterisk represents stop codon. b ChIP analysis
revealed that U1 snRNP’s departure is delayed in the prp28-K82Δ10 strain. Short lines in the top panel represent the amplicons used for monitoring
U1 snRNP recruitment. In the bottom panel, the amplicon numbers are denoted on X axis. Y axis represents relative enrichment of U1 signal to that of the
amplicon 1. Error bars are ± SEM; n = 3 biological repeats; ****P < 0.0001, unpaired two-tailed t-test. c Splicing reactions using radiolabeled ACT1 transcript
were done in wild-type extracts at 0.02, 0.05, 0.2, or 2 mM ATP and subjected to 254-nm UV irradiation (even-numbered lanes 6–20).
Immunoprecipitations after denaturation were done with anti-Prp28 (lanes 5–12) or with negative-control anti-V5 antibody (lanes 13–20). Relative loadings
are 1:1000 for splicing reactions alone (lanes 1–4) vs. immunoprecipitated reactions (lanes 5–20). The experiment was repeated three times with similar
results. d Primer extension revealed two strong reverse transcriptase stops. Sequencing ladder (lanes 1–4) allows assignment of the two stops to the high
conserved GU dinucleotide (lane 8, triangles) that remain after denaturation (Denat) and immunoprecipitation with anti-Prp28 antibody. Source data are
provided as a Source Data ﬁle.

Prp28 also contacts the conserved GU dinucleotide at the 5′
splice site. To address whether Prp28 also makes speciﬁc contact
with pre-mRNA, we irradiated the splicing reactions with UV
(254 nm) to induce protein-RNA cross-linking. The cross-linked
RNA was then immunoprecipitated under denaturing conditions.
We found that Prp28’s contact with pre-mRNA peaked at 0.05 mM
ATP (Fig. 2c), consistent with the native immunoprecipitation data
(Fig. 1a). Using oligonucleotide-directed RNase H cleavage followed by immunoprecipitation, we then assigned the contact point
to a small region covered by oligonucleotides (oligos) D and E, the
latter of which is downstream of 5′SS (Supplementary Fig. 7). To
map the contact sites precisely, we use a downstream oligo for
primer extension analysis. This analysis identiﬁed two strong
reverse transcriptase stops at the highly conserved GU dinucleotide
at the 5′SS under denaturing conditions (Fig. 2d). A previous
experiment28 using a different cross-linking method mapped
hPrp28 contacts to predominantly + 7 position downstream of the
5′SS consensus. Taken together, Prp28 appears to behave as a
conventional RNA helicase for unwinding the U1 snRNA/5′SS
short duplex to dislodge U1 snRNP from the pre-B complex.
4

Phosphorylated Npl3 potentiates Prp28’s ATPase activity. If
Prp28 is indeed a canonical RNA helicase, a vexing question
remains as to why it harbors only negligible ATPase activity. In
our BPA experiments, we noticed Prp28-E326BPA yielded a
particularly strong cross-linked product (Supplementary
Fig. 9a, b). Mass-spectrometry analysis indicated that this
protein is likely Npl3 (Supplementary Data 7 and Supplementary Figs. 8, 9c), a multifunctional SR-like RNA-binding protein
involved in splicing29 and mRNA export30 and loosely associated with the puriﬁed U1 snRNP29,31. Immunoblotting analysis validated this cross-linked species as the phosphorylated
form of Npl3 (p-Npl3) (Supplementary Figs. 9c and 10)32.
Genetic analysis shows that the prp28-E326Δ3 npl3Δ double
mutant exhibits a synthetic-lethal phenotype (Supplementary
Fig. 9d). Immunoprecipitation analysis revealed that p-Npl3
associates with ACT1 transcript in an ATP-independent fashion
throughout the course of the splicing reaction (Fig. 3a). ChIP
analysis reveals that U1 snRNP’s recruitment was dramatically
reduced in npl3Δ mutant (Fig. 3b and Supplementary Fig. 13),
whereas in prp28-E326Δ3 mutant U1 snRNP’s departure is
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Fig. 3 Npl3 is critical for U1 snRNP recruitment and phosphorylation of Npl3 activates Prp28’s ATPase activity. a p-Npl3 is associated with pre-mRNA
in an ATP-independent manner. Splicing reactions (lanes 1–5) were done in splicing extracts at 0, 0.02, 0.05, 0.2, or 2 mM ATP and a portion was
subjected to immunoprecipitation with either anti-Prp28 antibody (lanes 6–10), anti-p-Npl3 antibody (lanes 11–15), or pre-immune serum (lanes 16–20),
respectively. Relative loadings are 1:10 for splicing reactions alone (lanes 1–5) vs. immunoprecipitated reactions (lanes 6–20). The experiment was
repeated three times with similar results. b ChIP analysis showed that Npl3 is important for U1 snRNP recruitment. npl3Δ, npl3-deleted strain. Error bars are
± SEM; n = 3 biological repeats; ****P < 0.0001, *P < 0.05 (P = 0.0356), unpaired two-tailed t-test. c ChIP analysis revealed that U1 snRNP’s departure is
delayed in the prp28-E326Δ3 strain. Error bars are ± SEM.; n = 3 biological repeats; *P < 0.05 (P = 0.031), ****P < 0.0001, ***P < 0.001 (P = 0.0008),
unpaired two-tailed t-test. d, e Prp28 ATPase assay. Puriﬁed Prp28, Prp28-AAAD, Prp28-E326Δ3, p-Npl3, and Npl3 were assayed for their ATPase activity
in various combinations using [α-32P]-ATP as a substrate. The products were separated by thin-layer chromatography for phosphoimager quantitation.
Error bars are ± SEM; n = 3 biological repeats. f ChIP analysis showed that blocking S411 residue’s phosphorylation in Npl3 (npl3-S411A) resulted in
U1 snRNP accumulation in the spliceosome during co-transcriptional splicing. Error bars are ± SEM.; n = 6 biological repeats; ****P < 0.0001, **P < 0.01
(P = 0.0017), unpaired two-tailed t-test. Source data are provided as a Source Data ﬁle.

signiﬁcantly delayed (Fig. 3c). The fact that Prp28 lacks an Nterminal RS domain found in hPrp28, whose phosphorylation is
critical for stable integration of U4/U6.U5 tri-snRNP into pre-B
complex22, raised a possibility that p-Npl3 is a missing cofactor
for activating Prp28 ATPase. To test this hypothesis, we puriﬁed recombinant Prp28, Prp28-E326Δ3, Prp28-D341A/E342A
(DEAD motif changed into AAAD)10, Npl3, and p-Npl3
(Supplementary Fig. 9e) and examined their ATPase activities
either alone or in various combinations (Fig. 3d, e). We found
that only p-Npl3, but not Npl3, can promote Prp28’s ATPase
activity without the requirement of RNA addition (Fig. 3d, e).
Critically, this ATPase activity is lost when Prp28-E326Δ3 is
combined with p-Npl3. Finally, to assess the biological relevance of Npl3 phosphorylation at S411, which is phosphorylated by Sky132, we performed ChIP analysis using the npl3S411A mutant strain. U1 snRNP was found to cotranscriptionally accumulate at a higher level in npl3-S411A
than that in the wild-type strain (Fig. 3f). We, therefore, suggest
that p-Npl3 is a cofactor that stimulates Prp28’s ATPase
activity to remove U1 snRNP from the pre-B complex. However, the precise nature, such as the exact phosphorylation site
(s), of such p-Npl3 within the splicing complexes remains to be
determined.

Npl3 may correspond to the metazoan-speciﬁc N-terminal
region of Prp28. The hPrp28 has an N-terminal region, consisting of an RS domain (residues 1–221) and an anchor domain
(residues 286–356). A recent human Pre-B complex structure25
showed that this anchor domain, which is immediately Nterminal to the RecA1 domain, docks at the interface between
Prp8 N terminus and Snu114 (Supplementary Fig. 2c). Intriguingly, although this anchor domain is well conserved in
metazoans but it is completely absent in yeast (Supplementary
Fig. 2). This leaves a puzzle as to how Prp28 is recruited to the
yeast Pre-B complex. The fact that Prp28 physically interacts with
Npl3 during splicing (Supplementary Fig. 8c and Supplementary
Data 7) and that Npl3 also contains an RS domain suggest that
Npl3 may be a functional counterpart of the hPrp28 N-terminal
region. In this light, we suggest a working model (Fig. 4) in which
p-Npl3 may correspond to the human RS and anchor domains
and that its phosphorylation regulates Prp28’s ATPase activity.
The latter is especially important, because an inopportune ATP
hydrolysis may negatively impact on the reported Prp28’s
proofreading activity33. Our ﬁnding that phosphorylation at S411
activates Npl3 to promote Prp28’s ATPase activity also raises a
broader implication that a similar strategy may apply to other
DEAD/H-box helicases for spatial and temporal regulation within
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Fig. 4 Model for Prp28’s recruitment to the pre-B complex and its ATPase activation by p-Npl3. The yeast pre-B complex (left panel) contains U1 (blue),
U2 (green), U4/U4.U6 (white) snRNPs, which harbors Brr2 (yellow), Prp8 (orange) and Snu114 (red) proteins. In this diagram, U1, U2, U4/U4.U6, Brr2,
Prp8, and Snu114 are drawn to scale, shape, and orientation following the published yeast pre-B structure. In this structure, p-Npl3 (deep blue and a yellow
circle, which stands for phosphorylation) is already located at a site very close to the intron (thin red line) 5′SS. Exon 1 (ﬁlled red rectangular box) and exon
2 (empty rectangular box) are not drawn to the scale. In the middle diagram, Prp28 is recruited by p-Npl3 into the pre-B complex and then physically
contacts U1C, Brr2, Prp8, and Snu114, which may serve to orient Prp28 at the right time and the right place so that the p-Npl3-activated Prp28 can
hydrolyze ATP to expel U1 snRNP, resulting in the formation of U1-free B complex (right panel). The double-headed thick dash line (in red) above Brr2
(middle panel) depicts the reported and speculated Brr2 relocation, which may bring Brr2 to the vicinity of Prp28 for direct contact, thereby signaling Brr2
to remove U4 snRNP leading to the Bact complex (not shown). Finally, we note that p-Npl3 was found to remain bound to the later splicing complexes and
also to the spliced mRNA.

a complex environment. Finally, our data show that, through two
different regulatory routes, the function and behaviors of Prp28
and hPrp28 within the spliceosome are fundamentally kept in
evolution.
Methods
Yeast strains. Strains used in this study are described in Supplementary Data 1.
Plasmids and oligonucleotides. Plasmids and oligonucleotides used in this study
are described in Supplementary Data 2 and 3, respectively.
Antibodies and reagents. The following antibodies were used in this study: antiPrp8 (ref.34; 1:2000), anti-Snu114 (ref.34; 1:2000), and anti-Brr2 antibodies. All
three antibodies were gifts from Dr. Soo-Chen Cheng (Institute of Molecular
Biology, Academia Sinica, Taiwan). Note that the anti-Brr2 was raised against a
His-tagged Brr2 N-terminal fragment [aa 1–183] and is highly robust and speciﬁc
(at 1:2000 dilution) in detecting Brr2 in the yeast extract by immunoblotting or by
immunoprecipitation. The anti-p-Npl3 and anti-Npl3 were obtained from Dr.
Christine Guthrie (UCSF, USA) (ref.35; 1:2000). Note that anti-p-Npl3 detects only
p-Npl3, but not Npl3; anti-Npl3 detects both phosphorylated and nonphosphorylated Npl3. Anti-Prp40 was a gift from Dr. Paul Siciliano, University of
Minnesota (ref.36; 1:2000). Anti-Prp28 was raised in this lab (ref.37; 1:2000). In
addition, the following reagents were from commercial sources: p-Benzoyl-L-phenylalanine (Bpa) (Bachem), anti-HA.11 (ms, Cat # MMS-101R, Lot # B220850,
Covance, Clone: 16B12, 1:2000), anti-V5-TAG (ms, Cat # MCA1360, Lot # 0915,
Bio-Rad, Clone: SV5-PK1, 1:2000), anti-Maltose Binding Protein (MBP) (ms, Cat #
E8032S, Lot # 0101603, NEB, Clone: B48, 1:10,000), anti-GAPDH (ms, Cat #
G8795-200, Lot # 045M4799V, Sigma, 1:10000), HRP-conjugated anti-rabbit IgG
(H + L) (gt, Cat # 65–6120, Lot # QK229568, Invitrogen, 1:10,000–1:40,000), HRPconjugated anti-mouse IgG (H+L) (gt, Cat # 62–6520, Lot # QG215721, Invitrogen, 1:10,000~1:40,000), Immobilon Western Chemiluminescent HRP Substrate
(Millipore), SuperSignal West Femto Maximum Sensitivity Substrate (Thermo),
Polyvinylidene diﬂuoride membrane (AmershamTM Hybond 0.45 mm PVDF, GE),
Protein A-Sepharose (PAS) was obtained from GE Healthcare Life Sciences, Protein A Mag Sepharose Xtra (PAmS) (GE), Amylose Resin (New England Biolabs),
5-Fluoroorotic acid (5-FOA) (ZYMO RESEARCH), Proteinase K was purchased
from MD Bio Inc., and Fast SYBR Green Master Mix (Applied Biosystems), Perfect
RNA marker template mix (0.1–1 kb, Novagen, Cat # 69003-3).
Splicing extracts, radioactively labeled RNA, and splicing assays. Yeast wholecell extracts were prepared according to the liquid-nitrogen-grinding method38.
Actin precursor RNA substrates were synthesized in vitro as runoff transcripts
using SP6 RNA polymerase and labeled with [α-32P] UTP at 20 Ci/mmole, which
was deﬁned as 1× speciﬁc activity for the ACT1 pre-mRNA substrate. The 10×
speciﬁc activity was deﬁned as substrates labeled with [α-32P] UTP at 200 Ci/
mmole. The full-length transcript is puriﬁed from 5% polyacrylamide (acrylamidebisacrylamide [29:1]/8 M urea) gels. Standard splicing assays39 were carried out for
30 min at 25 °C unless otherwise indicated.
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Phosphorylated Npl3 add-back experiments. Two reactions (70 μl each), using
either wild-type or npl3Δ splicing extract, were assembled and incubated. Aliquots
(10 μl) were withdrawn at 5, 10, 15, 20, and 30 min and treated with proteinase K
to stop the reaction for analyzing the splicing progression. Because at 5 min, a
distinctive difference was observed between the two reactions, we, therefore, chose
the 5-min incubation time for subsequent add-back experiments. To test whether
p-Npl3 can rescue the delay of splicing in the npl3Δ reaction, puriﬁed p-Npl3 (see
below) was added into the reaction mix without ATP and pre-incubated for 10
min. ATP was then added to start the splicing reaction for a total of 5 min.
Co-Immunoprecipitation assay. Protein A Mag Sepharoses Xtra (10 µl) were prebound with 1 µl of polyclonal anti-p-Npl3 or with 2 µl of polyclonal anti-Npl3
complemented with 500-µl NET2 buffer (150 mM NaCl, 50 mM Tris-HCl [pH
7.4], 0.05% NP40), which was then placed on a rotating platform for 1–2 h at 4 °C.
After binding, the resin was washed three times with 1-ml ice-cold NET2 buffer
and stand on the ice. p-Npl3 (1.2 µg) or Npl3 (1.2 µg) was mixed with Prp28 (1.2
µg) under splicing condition without RNA transcript, incubated at 25 °C for 30
min, and then mixed with IgG-bound beads at 4 °C for 1 h. Beads were washed
with 1-ml cold NET2 three times. Bound proteins were separated by 4–20% gradient gel for probing with either anti-Prp28, anti-p-Npl3, or anti-Npl3 antibody. In
the reciprocal experiments, anti-Prp28 antibody (2 µl) was bound to the beads.
Immunoblotting. Standard immunoblotting analysis was used to detect Prp28 and
its covalently cross-linked products. In a typical Western procedure, anti-Prp28
polyclonal antibody (1:2000 dilution) and HRP-conjugated anti-rabbit IgG
(1:10,000 or 1:40,000 dilution, depending on the HRP substrate used subsequently)
were employed. Alternatively, mouse monoclonal anti-HA11 antibody (1:2000
dilution) and HRP-conjugated anti-mouse IgG (1:10,000 or 1:40,000 dilution) were
used. PVDF blotting membranes were used. Immobilon Western Chemiluminescent HRP Substrate was chosen for developing the Western blot when the secondary antibody was used in 1:10,000 dilution. For more sensitive detection,
SuperSignal West Femto Maximum Sensitivity Substrate was employed along with
1:40,000 dilution of the secondary antibody. Fujiﬁlm Super RX-N Blue X-Ray Film
was used for detecting chemiluminescence. The exposure time was typically from 1
to 10 min. For evaluation of Prp28 levels in wild-type and prp28 “small-deletion”
mutants, we picked two independent colonies for growth in 1 l YPD medium at 30
°C to 3–4 OD600. Yeast extracts were prepared by the liquid-nitrogen-grinding
method38. Equal protein amounts (20–30 μg) were loaded for SDS-PAGE, followed
by transfer to PVDF membranes, and for immunoblotting analysis. The same
method was used to examine Npl3 levels in the wild-type and the npl3Δ strains.
Anti-Npl3 and anti-p-Npl3 polyclonal antibodies (1:2000 dilution) and antiGAPDH monoclonal antibody (1:10,000 dilution) were used.
BPA-mediated cross-linking experiments. The BPA-cross-linking method has
been previously described in a step-by-step manner17, which includes cell growth
in the presence of BPA, extract preparation, spliceosome assembly on the MS2
loop-tagged ACT1 transcript, UV (365 nm) irradiation, spliceosome pull down,
denaturation of pull-down spliceosome, SDS-PAGE, and detection of the crosslinked species by speciﬁc antibodies. This detailed protocol17 also includes the
scale-up procedure for mass-spectrometry analysis.
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Detection of spliceosome-associated Prp28 by RNA pull-down experiment.
Method for using MS2 loop-tagged transcript to pull down assembled spliceosome
has been previously described in a step-by-step manner17, except, in this case, a
splicing extract containing V5-tagged Prp28 was used and neither BPA incorporation nor UV irradiation was employed. Prp28 was detected by an anti-V5
antibody.
Mass-spectrometry analysis. After silver-staining the gel, regions corresponding
to the locations of the cross-linked product in both lanes (with or without UV
irradiation) were excised and subjected to standard mass-spectrometry analysis
(LC–MS/MS). The puriﬁed recombinant protein (1.2 µg) of p-Npl3 was resolved by
SDS-PAGE and Coomassie-Blue stained, then the single band was retrieved and
analyzed for phosphorylation position by MS analysis (Supplementary Fig 10d).
The phosphopeptide MS analysis presented was done from the same batch of
phosphorylated Npl3 that was used in the ATP hydrolysis assay and in the in vitro
co-afﬁnity studies. Samples were detected by Nano-LC-NanoESI-MS/MS on an
Orbitrap Fusion mass spectrometer (ThermoFisher Scientiﬁc, San Jose, CA)
equipped with EASY-nLC 1200 system (Thermo, San Jose, CA, US) and EASYspray source (Thermo, San Jose, CA, US). The digestion solution was injected (5 μl)
at 1 μl/min ﬂow rate on to easy column (C18, 0.075 mm × 150 mm, ID 3 μm;
Thermo Scientiﬁc). Chromatographic separation was using 0.1% formic acid in
water as mobile phase A and 0.1% formic acid in 80% acetonitrile as mobile phase
B operated at 300 nl/min ﬂow rate. Brieﬂy, the gradient employed was 2% buffer B
at 2 min to 40% buffer B at 40 min. Full-scan MS condition: mass range m/z
375–1800 (AGC target 5E5) with lock mass, resolution 60,000 at m/z 200, and
maximum injection time of 50 ms. The MS/MS was run in top speed mode with 3-s
cycles with CID for protein id or ETD for phosphopeptide; while the dynamic
exclusion duration was set to 60 s with 10 ppm tolerance around the selected
precursor and its isotopes. Electrospray voltage was maintained at 1.8 kV and the
capillary temperature was set at 275 °C. Data analysis was analyzed as follows: Raw
ﬁle processed by Maxquant (Version 1.6.14.0). MS/MS spectra were searched
against the UniProt yeast database (UP000002311, 6049 entries) and enzyme
digestion by trypsin with 2 missed cleavage sites. The parameter such as MS
tolerance of 20 ppm for the ﬁrst search and main search 6 ppm. Fragment tolerance
was 0.5 Da (IT) or 0.01 Da (FT). Variable modiﬁcation of oxidation (M) and
acetylation (protein N-terminal) and ﬁxed modiﬁcation of carbamidomethyl (C) as
search parameters. To evaluate enrichment of the protein upon UV cross-linking,
we adopted the LFQ (Label-Free Quantiﬁcation) intensity of protein for
quantiﬁcation40,41. In addition, variable modiﬁcation of phospho (STY) for the
phosphopeptide identiﬁcation was analyzed and the localization probabilities were
ﬁltered larger than 0.95 (Supplementary Data 8). LC–MS/MS Quantiﬁcation of
site-speciﬁc phosphorylation degree of p-Npl3 was done by Xcalibur Qual Browser
4.1.31.9 (Supplementary Fig. 11). The mass-spectrometry experiments were done
by two biological repeats.
Immunoprecipitation of the spliceosome. To detect the physical association of
Prp28, p-Npl3, or Prp40 with spliceosome, we ﬁrst assembled spliceosome using
[32P]-labeled ACT1 transcript. Immunoprecipitation of spliceosome was performed
as described42. In these experiments, 1-μl anti-Prp28, 0.1-μl anti-p-Npl3, or 1-μl
anti-Prp40 antibody was pre-incubated with protein A-Sepharose. The splicing
reaction (10 μl) was then incubated with 10-μl antibody-coupled protein ASepharose (~2.5 mg) for precipitating the spliceosome. The precipitates were
washed with 1-ml cold NET-2 three times at room temperature. After proteinase K
treatment (1 mg/ml for 37 °C/30 min), RNAs were extracted for urea polyacrylamide (8%) gel electrophoresis.
Chromatin immunoprecipitation (ChIP) analysis. ChIP analysis was done exactly
as described7, except that anti-V5 (U1C-V5) and anti-Prp40 were used to precipitate the chromatin-bound U1 snRNP. Brieﬂy, 50 ml of ~0.8 OD600 yeast cells
were treated with formaldehyde (2%). Next, cells were resuspended in lysis buffer
and disrupted by bead beater. The insoluble cross-linked fraction was subjected to
sonication for shearing the DNA fragment to ~300 bp. Subsequently, immunoprecipitation of U1C-V5 or Prp40 was performed by anti-V5-PAS or anti-Prp40PAS beads at 4 °C overnight. After extensive washes, crosslinks were reversed and
DNA extracted. Primer pairs (Supplementary Table S3) covering the ACT1 gene
were used in qPCR experiments. All data represent an average of three independent
experiments. Error bars are ±SEM. The enrichment of the U1C-bound or Prp40bound chromatin over the background was normalized to that of primer set 1 data
points.
Genetic screen of the prp8-501 mutation. YTC302 (MATa prp28::HIS3 YHC1-1
ade2 ade3 pCA8105-PRP28/ADE3/URA3) were grown in YPD (1% yeast extract,
2% bacto-peptone and 2% glucose), diluted and plated to YPD containing 4%
glucose (4% YPD). Plates were exposed to 254-nm UV to obtain an 80–90% killing
rate and incubated at 30 °C. Colonies that did not appear to the sector were picked
and re-streaked twice to 4% YPD. Those remaining non-sectoring were tested on
media containing 1 mg/ml 5-FOA to select against cells containing the URA3 gene.
5-FOA-sensitive clones were transformed with pCA8034-PRP28/LEU2. Candidates
able to sector and become 5-FOA resistant were tested for reversion of the YHC1-1
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locus by introducing pYHC1003-YHC1-1/LEU2. Those that remained 5-FOA
sensitive were isolated. One strain that met all the criteria is YTC303 (MATa
prp28::HIS3 YHC1-1 prp8-501 pCA8105). This was crossed to a non-mutagenized
isogenic strain YTC301 (MATα prp28::HIS3 YHC1-1 PRP8 pCA8105-PRP28/
ADE3/URA3). Sectoring and viability on 5-FOA were restored, indicating the
mutation is recessive. Tetrad analysis of the resulting diploid yielded 2:2 segregation for survival on 5-FOA indicating that a single gene had been mutated. YTC303
was then transformed with a wild-type YCp50-based (LEU2-marked) genomics
library. Transformants that regained the ability to sector were chosen and the
library plasmid was recovered and sequenced. The library clone contained only the
PRP8 open reading frame, revealing that a mutation in PRP8 was synthetically
lethal with prp28Δ YHC1-1. The library plasmid containing wild-type PRP8 is
pPRP8001 (YCp50-PRP8). The region of PRP8 containing the synthetic-lethal
mutation was identiﬁed by gap repair using pPRP8002-PRP8/TRP1 that was
gapped separately with three enzymes, AﬂII, AgeI, and BstEII. Linearized gapped
plasmids were then transformed into YTC303. Only the plasmid that was gapped
with BstEII plasmid failed to provide relief from synthetic lethality. This plasmid
was rescued and sequenced to identify prp8-501 and was named pPRP8003.
Mutant alleles of prp8 were obtained from other laboratories (Supplementary
Table 7). Plasmids carrying the mutant alleles of PRP8 were tested for synthetic
lethality with prp28Δ YHC1-1 by introduction into YTC307 (prp28::HIS3 YHC1-1
prp8::LYS2 pJU169-PRP8/URA3). Transformation of prp8 mutant alleles was followed by selection on media containing 1 mg/ml 5-FOA. Plasmids that conferred
synthetic lethality were rescued from the yeast strain and sequenced to verify the
mutation within PRP8 that caused lethality. To ensure that the PRP8 alleles causing
lethality on 5-FOA were synthetically lethal and not null mutations, plasmids were
transformed into YJU75 (prp8::LYS2 pJU169-PRP8/URA3) and the transformants
were found to be 5-FOA viable.
Genetic analysis of prp28, brr2, and npl3. To construct the prp28 tester strains,
we individually transformed plasmids pRS415-prp28-K27Δ10, pRS415-prp28K41Δ10, pRS415-prp28-K82Δ10, or pRS415-prp28-K136Δ10 into YTC1282 and
counter-selected pRS316-PRP28 by plating the cells on SC-Leu/5-FOA plate. The
prp28 tester strains were crossed with strain YTC1446 (MATa, brr2Δ::natMX4
pRS416-BRR2) and the diploid cells were sporulated. We selected the haploid
testers with prp28Δ::kanMX4, pRS415-prp28 alleles, brr2Δ::natMX4, and pRS416BRR2. The haploid tester strains were further transformed with pRS413-BRR2,
pRS413-brr2-A1710T, pRS413-brr2-G1708*, pRS413-brr2-K2095*, pRS413-brr2L1971*, pRS413-brr2-Q2037*, pRS413-brr2-Q1354K, pRS413-brr2-R1107A43,
respectively. The transformants were spotted on SC-His/-Leu/5-FOA plates. The
inviable or slow growth cells indicated synthetic lethality or sickness of tested prp28
alleles and tested brr2 alleles. The prp28 tester strain (prp28Δ::kanMX4, pRS415prp28-E326Δ3) was mated with the npl3 deletion strain (BY4741 MATa, npl3Δ::
natMX4) and the resulting diploids were sporulated. We selected the haploid
containing prp28Δ::kanMX4, pRS415-prp28-E326Δ3, npl3Δ::natMX4 for
spotting assay.
UV cross-linking of Prp28 to pre-mRNA. Splicing reactions (25 µl each) were
carried out in a 12-well culture plate with 10X speciﬁc activity of ACT1 pre-mRNA
substrate (2 nM) for 30 min, quenched on ice, and then UV-irradiated (254 nm;
0.8 J/cm2) on ice in a CL-1000 Ultraviolet Crosslinker (UVP). The UV light source
is placed ~5 cm above the sample. UV-irradiated samples were denatured in 1%
SDS (w/v), 1% Triton X-100 (v/v), and 100 mM DTT, heated in boiling water for
90 sec, and then placed at 25 °C for 2 min. The denatured samples were centrifuged
in a microfuge at 16,363 × g for 1 min at room temperature. The supernatants were
removed to new tubes. Before immunoprecipitation, the concentration of denaturants was reduced by 10-fold dilution with NET-2–300 (300 mM NaCl, 50 mM
Tris-HCl [pH 7.4], 0.05% NP40) and tRNA added at a ﬁnal concentration of 200
µg/ml. The mixtures were incubated with 25 µl of antibody-conjugated protein A
Sepharose (PAS) for 1.5 h at 4 °C. The precipitates were washed with 1 ml of cold
NET-2–300 ﬁve times and 1 ml of room temperature NET-2 (150 mM NaCl, 50
mM Tris-HCl [pH 7.4], 0.05% NP40) twice. Finally, after proteinase K treatment
(1 mg/ml for 37 °C/30 min), RNAs were extracted and dissolved each in 10 µl
formamide dye for denaturing urea gel (8%) electrophoresis.
Oligonucleotide-directed RNase H and primer extension experiments. A 70-μl
splicing reaction containing 2 nM of radiolabeled (10× speciﬁc activity; 200 Ci/
mmol) M3-ACT1 pre-mRNA and 0.05 mM ATP was ﬁrst assembled, from which
an aliquot of 1 μl was removed as “untreated” control. The remaining mix was
treated with 5 μM oligonucleotide in a total of 73 μl reaction for 20 min at 25 °C,
from which an aliquot of 1 μl was removed as an oligonucleotide-treated control.
From the remaining volume, a 10-μl aliquot was removed and incubated with antiPrp28-PAS for 1.5 h at 4 °C as an immunoprecipitation control. The rest of 60 μl
was then split into two halves, one of which was irradiated with UV and the other
was not. Both were then denatured, treated, and immunoprecipitated as described
above. RNAs from untreated control and oligonucleotide-treated control were
extracted and dissolved in 200 and 20 µl formamide dye, respectively. The RNA
from immunoprecipitated control was extracted and dissolved in 20 µl formamide
dye. The RNAs from denatured reactions were extracted and each dissolved in 5 µl
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formamide dye. An equal volume (5 µl) from all those samples was then analyzed
by denaturing urea gel (8%) electrophoresis. To map Prp28’s contact site on premRNA, we scaled up the reaction markedly to 60 ml. All the steps before the
primer extension step are the same as described for the RNase H experiment. For
primer extension analysis, RNA was isolated from 60 ml of splicing reaction
mixture after UV irradiation. Each RNA sample was mixed with a 5′-end [32P]labeled oligonucleotide #6 (4 × 105 cpm), denatured by heating at 65 °C for 5 min,
and quickly chilled on ice. Primer extension reactions were carried out with
RevertAid H Minus First Strand cDNA Synthesis Kit (Thermo) at 42 °C for 1 h.
DNA products were recovered after degrading the RNA by NaOH and fractionated
on an 8% sequencing gel (acrylamide-bisacrylamide [19:1]/8 M urea) and visualized by autoradiography. The same primer was used to generate the sequencing
ladder using pSPACT1 as a template. Sequencing reactions were done by using
SequenceTM Version 2.0 DNA Sequencing Kit (Affymetrix).
Puriﬁcation of recombinant Prp28WT and Prp28AAAD proteins. We typically
grew 6 l of E. coli culture for purifying recombinant Prp28WT or Prp28AAAD
protein. Two plasmids were created under the pRSET-A (Addgene) vector backbone carrying wild-type yeast Prp28WT and its mutant Prp28AAAD protein-coding
regions in frame with N-terminal 6-His tag. E. coli Rosetta cells (Stratagene) were
employed and protein expression was induced by adding 0.3 mM IPTG at 37 °C for
3 h. Cells were collected by centrifugation and resuspended in a buffer containing
50 mM KH2PO4, 50 mM Na2HPO4 (pH 7.4), 500 mM NaCl, 3 mM β-mercaptoethanol, 7.5% (v/v) glycerol, supplemented with complete EDTA-free protease
inhibitor cocktail (Roche). The cells were harvested and lysed with a microﬂuidizer
and the lysate was centrifuged in a JA25.50 rotor (Beckmann Coulter) at 34,957 × g
for 40 min at 4 °C. Then, the supernatant was mixed with Ni-Sepharose 6 Superﬂow afﬁnity resins (Qiagen) for 30 min at 4 °C followed by a stepwise prewash with
buffer contains 25 mM and 50 mM imidazole. After that, Prp28pWT and
Prp28pAAAD proteins were eluted with buffer containing 250 mM imidazole.
Eluted proteins were pooled and dialyzed for 16 h at 4 °C in a buffer containing 20
mM HEPES (pH 7.4), 150 mM NaCl, 3 mM dithiothreitol, and 7.5% (v/v) glycerol.
After dialysis, protein samples were loaded into MonoS 5/50 GL column (GE
Healthcare Life Sciences), equilibrated in a buffer containing 20 mM HEPES (pH
7.4), 150 mM NaCl, 3 mM dithiothreitol, and 7.5% (v/v) glycerol, and bound
proteins were eluted with a linear gradient of NaCl concentration to 1 M. Proteincontaining fractions were loaded onto a HiLoad 200 10/300 GL column (GE
Healthcare Life Sciences) equilibrated in a buffer containing 20 mM HEPES (pH
7.4), 150 mM NaCl, 3 mM dithiothreitol and 7.5% (v/v) glycerol. Proteins fractionated (0.5 ml) from HiLoad 200 10/300 GL column (GE Healthcare Life Sciences) were collected and analyzed by Coomassie-stained SDS-PAGE (12%) and
for mass-spectrometry analysis. These two proteins were concentrated to 0.4 mg/ml
in 20 mM HEPES (pH 7.9), 0.2 mM EDTA, 50 mM KCl, 20% glycerol, 0.5 mM
DTT and stored at −80 °C.

serum albumin, and 0.8 mM dithiothreitol. The reaction was incubated at 37 °C for
2.5 h and stopped with 4 µl of 100 mM EDTA. 2 µl of the reaction was spotted onto
a TLC (PEI) plate, which was developed with a buffer containing 0.375 M potassium phosphate at pH 3.5 for 1.5 h to separate ADP and ATP. The amount of ATP
hydrolyzed was quantiﬁed using a PhosphorImager on a Typhoon scanner (GE
Healthcare).
Statistical analysis and software. The cryo-EM structure of the labeled human
pre-B complex (Protein Data Bank 6QX9) was displayed by PyMol 2.3.2 (Supplementary Fig. 2c and Supplementary Software 1). Gels and TLC (PEI) plate were
exposed to GE Storage Phosphor Screen (GE Healthcare Life Sciences). RNA bands
and the amount of ATP hydrolyzed were quantiﬁed with TyphoonTM FLA9000
(GE Healthcare Life Sciences) and analyzed with ImageQuant TL7.0 (GE Healthcare Life Sciences). All statistics were performed using GraphPad Prism 8
(Graphpad). Data are presented as the mean ± SEM. Statistical signiﬁcance between
the two groups was determined with an unpaired two-tailed Student’s t-test. ChIP
experiments were carried out with n = 3 biological repeats (Figs. 2b, 3b, c, and
Supplementary Fig. 1c), and n = 6 biological repeats (Fig. 3f). Prp28 ATPase assay
was carried out with n = 3 biological repeats (Fig. 3e). Quantiﬁcation of retained
U1 snRNP from spliceosome was carried out (Supplementary Fig. 6b), n = 3
biological repeats.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.

Data availability
The raw mass-spectrometry proteomics data have been deposited to the
ProteomeXchange Consortium via the PRIDE partner repository with the data set
identiﬁers PXD024492 (Prp28-K136BPA)44; PXD024493 (Prp28-E326BPA)45;
PXD024494 (p-Npl3)46. The uncropped gel or blot ﬁgures and original data underlying
Figs. 1–3 and Supplementary Figs. 1–13 are provided as a Source Data ﬁle47. All data
supporting the ﬁndings of this study are available from the corresponding authors upon
reasonable request. Source data are provided with this paper.
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